PDLI PDL BioPharma Inc

Protein Design Labs Announces Webcast of Third Quarter Conference Call FREMONT, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Protein Design Labs, Inc. (PDL) today announced that its financial results for the nine-month period ended September 30, 2003 will be released following the close of the U.S. financial markets on November 3, 2003. PDL will hold a conference call to discuss these results, the status of its clinical development programs, and its forward-looking information and guidance with respect to the remainder of 2003 at 4:30 p.m. Eastern time on November 3, 2003. The live webcast will be available through the PDL website: http://www.pdl.com/. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at http://www.pdl.com/ starting approximately one hour after completion of the webcast. An audio replay will also be available by telephone from approximately 6:30 p.m. Eastern time on November 3, 2003 through 6:30 p.m. Eastern time on November 6, 2003. To access the replay, dial 800-633-8284 from inside the United States and 402-977-9140 from outside the United States; enter conference ID number 21164446. Protein Design Labs is a leader in the development of humanized antibodies to prevent or treat various disease conditions. PDL currently has antibodies under development for autoimmune and inflammatory conditions, asthma and cancer. PDL holds fundamental patents for its antibody humanization technology. Further information on PDL is available at http://www.pdl.com/. NOTE: Protein Design Labs is a registered U.S. trademark and the PDL logo is a trademark of Protein Design Labs, Inc. DATASOURCE: Protein Design Labs, Inc. CONTACT: James R. Goff, Senior Director, Corporate Communications of Protein Design Labs, Inc., +1-510-574-1421, or Web site: http://www.pdl.com/

Copyright